LTFS
AMRI

Ladenburg Thalmann Financial Services’s Albany Molecular Research Inc AMRI Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-340
Closed -$5K – 4944
2016
Q1 		$5K Sell
340
-1,091
-76% -$17.1K ﹤0.01% 4115
2015
Q4 		$29K Buy
1,431
+737
+106% +$14K ﹤0.01% 2972
2015
Q3 		$12K Buy
694
+354
+104% +$7.21K ﹤0.01% 3444
2015
Q2 		$7K Hold
340
– – ﹤0.01% 3929
2015
Q1 		$6K Hold
340
– – ﹤0.01% 3928
2014
Q4 		$6K Sell
340
-40
-11% -$734 ﹤0.01% 3695
2014
Q3 		$8K Hold
380
– – ﹤0.01% 3246
2014
Q2 		$8K Buy
380
+40
+12% +$678 ﹤0.01% 3210
2014
Q1 		$6K Buy
+340
New +$4.68K ﹤0.01% 3220

Other funds holding AMRI

PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AMRI Position: Q2 2016 in Review

Ladenburg Thalmann Financial Services sold out of Albany Molecular Research Inc (AMRI) in Q2 2016, closing a stake of 340 shares — an estimated $5K sold.

Ladenburg Thalmann Financial Services first reported a position in AMRI in Q1 2014 and held it in 9 quarters. The position peaked at $29K in Q4 2015. 142 funds tracked by Wall St. Rank hold AMRI as of Q2 2016.

  • Ladenburg Thalmann Financial Services reported no remaining Albany Molecular Research Inc position as of Q2 2016 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 340 Albany Molecular Research Inc shares in Q2 2016, an estimated $5K.
  • Ladenburg Thalmann Financial Services first reported a position in Albany Molecular Research Inc in Q1 2014 and held it in 9 quarters.
  • Ladenburg Thalmann Financial Services's Albany Molecular Research Inc position peaked at $29K in Q4 2015.
  • 142 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2016.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2016, filed 15 Aug 2016.